Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Merrimack platform now uses SimBiology
August 2007
SHARING OPTIONS:

NATICK, Mass.The MathWorks has announced that Merrimack Pharmaceuticals is using its SimBiology tool to streamline the research and development of therapeutics to treat autoimmune disease and cancer. SimBiology is said to play an integral role in Merrimack's discovery platform, Network Biology, which comprises multidisciplinary, integrating computational tools from engineering and high-throughput biology to guide drug design and development.
 
"In order to compete in an industry dominated by large pharmaceutical companies with larger research efforts, we've adopted a unique approach to drug discovery that incorporates the principles of model-based design," says Birgit Schoeberl, director of Network Biology at Merrimack Pharmaceuticals. "SimBiology and other MathWorks tools have been instrumental in giving us the competitive edge we need, [making] it easy to create and share models of pathways with other teams throughout each stage of research and development."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.